These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7262512)

  • 1. Evidence for impairment of transsulfuration pathway in cirrhosis.
    Horowitz JH; Rypins EB; Henderson JM; Heymsfield SB; Moffitt SD; Bain RP; Chawla RK; Bleier JC; Rudman D
    Gastroenterology; 1981 Oct; 81(4):668-75. PubMed ID: 7262512
    [No Abstract]   [Full Text] [Related]  

  • 2. Remethylation and transsulfuration of methionine in cirrhosis: studies with L-[H3-methyl-1-C]methionine.
    Russmann S; Junker E; Lauterburg BH
    Hepatology; 2002 Nov; 36(5):1190-6. PubMed ID: 12395329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of glutathione in response to methionine load in control subjects and in patients with cirrhosis.
    Bianchi G; Brizi M; Rossi B; Ronchi M; Grossi G; Marchesini G
    Metabolism; 2000 Nov; 49(11):1434-9. PubMed ID: 11092507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation.
    Tietge UJ; Bahr MJ; Manns MP; Böker KH
    Transpl Int; 2003 Jan; 16(1):1-8. PubMed ID: 12545334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tracer method for measuring rate of urea synthesis in normal and cirrhotic subjects.
    Rypins EB; Henderson JM; Fulenwider JT; Moffitt S; Galambos JT; Warren WD; Rudman D
    Gastroenterology; 1980 Jun; 78(6):1419-24. PubMed ID: 7372062
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis.
    Spahr L; Negro F; Leandro G; Marinescu O; Goodman KJ; Rubbia-Brandt L; Jordan M; Hadengue A
    Med Sci Monit; 2003 Jan; 9(1):CR6-11. PubMed ID: 12552242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle free amino acids in liver cirrhosis.
    Montanari A; Perinotto P; Novarini A
    Ital J Gastroenterol; 1993 Apr; 25(3):138-43. PubMed ID: 8507891
    [No Abstract]   [Full Text] [Related]  

  • 8. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
    Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M
    Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma tyrosine concentrations in patients with cirrhosis and fulminant hepatic failure associated with increased plasma tyrosine flux and reduced hepatic oxidation capacity.
    O'Keefe SJ; Abraham R; El-Zayadi A; Marshall W; Davis M; Williams R
    Gastroenterology; 1981 Dec; 81(6):1017-24. PubMed ID: 7286580
    [No Abstract]   [Full Text] [Related]  

  • 10. [Various aspects of S35-methionine metabolism in liver cirrhosis].
    Szantay I; Szirmai E; Cotul S
    Acta Oncol (Madr); 1970; 9(2):220-5. PubMed ID: 5518558
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolism of S35 methionine in liver cirrhosis].
    Szantay I; Szirmai E; Cotul S
    Presse Med (1893); 1971 Feb; 79(9):399. PubMed ID: 5546800
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of free amino acids in the plasma and urine of patients with liver cirrhosis].
    Rosić D; Pokrrjcić G; Obradović M; Rosić J
    Acta Med Iugosl; 1975; 29(3):265-70. PubMed ID: 1146604
    [No Abstract]   [Full Text] [Related]  

  • 13. Transamination of methionine after loading in patients with cirrhosis.
    Bugianesi E; Tangerman A; Ronchi M; Bianchi G; Marchesini G
    J Hepatol; 1996 Jan; 24(1):95-100. PubMed ID: 8834031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.
    Fabbri A; Marchesini G; Bianchi G; Bugianesi E; Bortoluzzi L; Zoli M; Pisi E
    Hepatology; 1993 Jul; 18(1):28-35. PubMed ID: 8325618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-adenosyl-L-methionine and the liver.
    Ortiz P; Moreno J; Puerta JL; Mato JM
    Ital J Gastroenterol; 1993 Apr; 25(3):135-7. PubMed ID: 8507890
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetics of mefenamic acid in patients with liver cirrhosis].
    Tkaczewski W; Adamska-Dyniewska H; Gajewska B; Kowalczyk L
    Pol Tyg Lek; 1978 Dec; 33(52):1997-9. PubMed ID: 733631
    [No Abstract]   [Full Text] [Related]  

  • 17. Mass flux balance-based model and metabolic flux analysis for collagen synthesis in the fibrogenesis process of human liver.
    Calik P; Akbay A
    Med Hypotheses; 2000 Jul; 55(1):5-14. PubMed ID: 11021318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some aspects of 35S-methionine metabolism in hepatic cirrhosis.
    Szantay J; Szirmai E; Cotul S
    Mater Med Pol; 1974; 6(2):120-2. PubMed ID: 4431243
    [No Abstract]   [Full Text] [Related]  

  • 19. Defective nonoxidative leucine degradation and endogenous leucine flux in cirrhosis during an amino acid infusion.
    McCullough AJ; Mullen KD; Kalhan SC
    Hepatology; 1998 Nov; 28(5):1357-64. PubMed ID: 9794922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphur amino acid pattern in chronic liver disease.
    Almasio P; Bianchi G; Marchesini G; Luca A; Bugianesi E; Le Grazie C; Pagliaro L
    Ital J Gastroenterol; 1994; 26(1):21-5. PubMed ID: 8025302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.